Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27012550)
Watch
English
CD40 immunotherapy for pancreatic cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
title
CD40 immunotherapy for pancreatic cancer
(English)
0 references
main subject
immunotherapy
1 reference
based on heuristic
inferred from title
pancreatic cancer
1 reference
based on heuristic
inferred from title
author name string
Robert H. Vonderheide
series ordinal
1
1 reference
stated in
Crossref
David L. Bajor
series ordinal
2
1 reference
stated in
Crossref
Rafael Winograd
series ordinal
3
1 reference
stated in
Crossref
Rebecca A. Evans
series ordinal
4
1 reference
stated in
Crossref
Lauren J. Bayne
series ordinal
5
1 reference
stated in
Crossref
Gregory L. Beatty
series ordinal
6
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
May 2013
1 reference
stated in
PubMed
published in
Cancer Immunology, Immunotherapy
1 reference
stated in
PubMed
volume
62
1 reference
stated in
PubMed
issue
5
1 reference
stated in
PubMed
page(s)
949-54
1 reference
stated in
PubMed
cites work
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
21 March 2017
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
21 March 2017
CD40-CD40 ligand
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
21 March 2017
Molecular and biological characterization of a murine ligand for CD40
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
21 March 2017
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
7 April 2017
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
7 April 2017
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
7 April 2017
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
7 April 2017
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
7 April 2017
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
7 April 2017
Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Agonistic CD40 antibodies and cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Advances in therapeutic vaccines for pancreatic cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Cancer immunoediting by the innate immune system in the absence of adaptive immunity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Prospect of targeting the CD40 pathway for cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Eradication of established tumors in mice by a combination antibody-based therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
CD40/CD154 interactions at the interface of tolerance and immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 September 2017
Giving blood: a new role for CD40 in tumorigenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
31 May 2018
Immunology. Licence to kill
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS00262-013-1427-5
retrieved
21 January 2018
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS00262-013-1427-5
retrieved
21 January 2018
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS00262-013-1427-5
retrieved
21 January 2018
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS00262-013-1427-5
retrieved
21 January 2018
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1007%2FS00262-013-1427-5
retrieved
21 January 2018
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 November 2018
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3731141
retrieved
28 November 2018
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23589109
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23589109
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23589109
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23589109
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23589109
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1007/S00262-013-1427-5
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4774914
Dimensions Publication ID
1035010416
0 references
OpenCitations bibliographic resource ID
4774914
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4774914
PMC publication ID
3731141
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4774914
PubMed publication ID
23589109
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4774914
ResearchGate publication ID
236185691
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
